The mechanism of baicalin against CMS-induced depression was partially achieved by increasing levels of DCX, neuron-specific enolase (NSE), and BDNF, reducing oxidative stress, and modulating the GSK3/NF-κB/NLRP3 signal cascade in the HIP [185]. The gene discussed is ENO2; the disease is depressive disorder.